Results 81 to 90 of about 1,390,389 (383)

Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review

open access: yesRadiation Oncology, 2020
Purpose To compare the efficacy and toxicity of hypofractionated radiotherapy versus conventional fractionated radiotherapy in postmastectomy breast cancer using meta-analysis.
Lei Liu   +7 more
doaj   +1 more source

Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases

open access: yesPhysics and Imaging in Radiation Oncology, 2022
Background and purpose: Magnetic resonance (MR)-linac delivery is expected to improve organ at risk (OAR) sparing. In this study, OAR doses were compared for online adaptive MR-linac treatments and conventional cone beam computed tomography (CBCT)-linac ...
Anita M. Werensteijn-Honingh   +13 more
doaj   +1 more source

Skin toxicity after radiotherapy. About a case [PDF]

open access: yes, 2015
A 60-year-old woman was admitted to the Department complaining of a slow growing mass in the right knee. Physical examination demonstrated a mass on the postero-lateral aspect of the right knee, which was not tender or mobile, however was rubbery and ...
Calvieri, Stefano   +6 more
core   +1 more source

MicroRNA 196a contributes to the aggressiveness of esophageal adenocarcinoma through the MYC/TERT/NFκB axis

open access: yesMolecular Oncology, EarlyView.
mir‐196a promotes Esophagus Adenocarcinoma aggressiveness. On one hand, mir‐196a targets the valosin‐containing protein (VCP) mRNA, causing the accumulation of c‐MYC protein that leads to high amounts of TERT. On the other hand, mir‐196a targets the inhibitor of NFκB (NFKBIA).
Jesús García‐Castillo   +8 more
wiley   +1 more source

Correction to: From IB2 to IIIB locally advanced cervical cancers: report of a ten-year experience

open access: yesRadiation Oncology, 2018
In the original publication [1] one author name was spelled incorrect.
Sophie Espenel   +15 more
doaj   +1 more source

Immune targets in the tumor microenvironment treated by radiotherapy. [PDF]

open access: yes, 2019
Radiotherapy (RT), the major anti-cancer modality for more than half of cancer patients after diagnosis, has the advantage of local tumor control with relatively less systematic side effects comparing to chemotherapy.
Li, Jian Jian   +2 more
core  

Radiotherapy: Impact of quality of life and need for psychological care: Results of a longitudinal study [PDF]

open access: yes, 2000
Background: In the framework of a prospective longitudinal study, the quality of life (QoL) and support requirements of patients from a university hospital department of radiotherapy were evaluated for the first time by means of established ...
Aydemir, U.   +6 more
core   +1 more source

The impact of Coronavirus (COVID-19) on head and neck cancer patients' care [PDF]

open access: yes, 2020
The impact of Coronavirus (COVID-19) on head and neck cancer patients ...
De Felice, Francesca   +2 more
core   +1 more source

Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy

open access: yesInternational Journal of Molecular Sciences, 2019
Radiotherapy (RT), besides cancer cells, also affects the tumor microenvironment (TME): tumor blood vessels and cells of the immune system. It damages endothelial cells and causes radiation-induced inflammation.
Magdalena Jarosz-Biej   +3 more
semanticscholar   +1 more source

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy